RYE BROOK, N.Y.–(BUSINESS WIRE)–Apr. 4, 2022– Xylem Inc. (NYSE: XYL), a leading global water technology company dedicated to solving the world’s most challenging water issues, will release its first quarter 2022 results at 6:55 a.m. (ET) on Wednesday, May 4, 2022. At 9:00 a.m. (ET), Xylem’s senior management team will host a conference call with... Read more
CHICAGO – April 4, 2022 – GE Healthcare announced today the FDA pre-market approval (PMA) for its End-tidal (Et) Control software for general anesthesia delivery on its Aisys CS2Anesthesia Delivery System. GE Healthcare is the only manufacturer approved to offer general anesthesia delivery with end-tidal concentration control in the U.S. The company initially released the... Read more
Three GE Healthcare solutions are among six named finalists for the 2022 Medical Design Excellence Awards – CT in a Box in the Radiological, Imaging, and Electromechanical Devices category; Mural Virtual Care Solution in the Digital Health Products and Mobile Medical Apps category; and the Oregon Capacity System in the Digital Health Products and Mobile... Read more
WASHINGTON, March 21, 2022 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the first quarter 2022 on Thursday, April 21, 2022 beginning at 8:00 a.m. ET and lasting approximately 1 hour. The call and an accompanying slide presentation will be webcast on the “Investors” section of... Read more
BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced that its Board of Directors has appointed Philip Ma, Ph.D. to serve on its board, effective as of April 1, 2022. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220316005639/en/ Dr. Philip Ma is Chief Executive Officer, President, and Founder of PrognomiQ (Photo: Business... Read more
MENLO PARK, Calif., Feb. 25, 2022 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced that the Compensation Committee of the Company’s Board of Directors granted non-qualified stock options covering an aggregate of 100,000 shares of PacBio common stock, and restricted stock units (“RSUs”) covering 50,000 shares... Read more
MENLO PARK, Calif., Feb. 15, 2022 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB) today announced financial results for the quarter and fiscal year ended December 31, 2021. Updates since our last earnings release Achieved record fourth quarter revenues of $36.0 million reflecting growth of 33% compared to the prior year period and grew the Sequel II/IIe... Read more
BOSTON – February 14, 2022 – GE (NYSE: GE) announced the appointment of Frank Jimenez as Vice President & General Counsel of GE Healthcare effective February 21, 2022. In this role, Frank will be responsible for GE Healthcare’s Global Law and Policy teams. Pete Arduini, chief executive officer of GE Healthcare, said, “Frank’s proven leadership... Read more
BOSTON – February 14, 2022 – GE (NYSE: GE) announced the appointment of Frank Jimenez as Vice President & General Counsel of GE Healthcare effective February 21, 2022. In this role, Frank will be responsible for GE Healthcare’s Global Law and Policy teams. Pete Arduini, chief executive officer of GE Healthcare, said, “Frank’s proven leadership... Read more